76%
Finnrick rating
#3 of 178 Tirzepatide vendors
2 of 4 classifiable tests passed
natural 50%
methodology · Purity focus
Finnrick analysis · Tirzepatide

Pure Rawz tirzepatide is held back by a later same-batch purity reversal: two May 21 results landed near 99.05% after earlier clears. Identity and fill stayed within this model, but evidence is narrow and lacks customer corroboration.

methodology →
vendor intelligence report
Vendor Intelligence Report: Pure Rawz

We investigated who actually operates Pure Rawz — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

23 pages8 risk factors assessed13 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatideselected
$23.29
76%
4
2
Retatrutide
$34.21
75%
4
3
Semaglutide
$26.22
64%
4
4
Melanotan II
$5.15
64%
4
5
Ipamorelin
$12.62
61%
5
6
BPC-157
$12.26
50%
4
7
CJC-1295
$11.44
20%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%7 May 2025: 67%7 May 2025: 69%21 May 2025: 63%21 May 2025: 60%13 Jul 2026: current 76%67%76%May 25Jul 26
Showing Tirzepatide tests only
Pure Rawz Tirzepatide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
21 May 2025Fail
Tested
lab nameView COA
21 May 2025Fail
Tested
lab nameView COA
7 May 2025Pass
Tested
lab nameView COA
7 May 2025Pass
Tested
lab nameView COA

About Pure Rawz test results from Finnrick

Pure Rawz is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 29 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Pure Rawz peptides in this dataset are Tirzepatide (4 tests), Retatrutide (4 tests) and Melanotan II (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 29 recent tests.

Corrections
No corrections.